Unnamed: 0,ID,Description,GeneRatio,BgRatio,pvalue,p.adjust,qvalue,geneID,Count
GO:0007159,GO:0007159,leukocyte cell-cell adhesion,26/71,381/18800,3.09980104926084e-26,7.196474667401141e-23,3.87734185927304e-23,ADAM8/B2M/CD27/CD28/CD5/CD70/CD74/CD80/CD83/CD86/CRTAM/GCNT1/HLA-E/IL10/IL12B/IL2RA/KLRK1/LAG3/LGALS9/LILRB4/PTPRC/SELL/TIGIT/TNF/TNFRSF13C/VCAM1,26
GO:0050863,GO:0050863,regulation of T cell activation,25/71,342/18800,6.08838804348658e-26,7.196474667401141e-23,3.87734185927304e-23,ADAM8/B2M/CD27/CD28/CD5/CD70/CD74/CD80/CD83/CD86/CRTAM/HLA-E/IL10/IL12B/IL2RA/KLRK1/LAG3/LGALS9/LILRB4/PTPRC/TIGIT/TNFRSF13C/TNFRSF1B/TNFSF8/VCAM1,25
GO:0050670,GO:0050670,regulation of lymphocyte proliferation,22/71,230/18800,2.23554497263075e-25,1.76160943843303e-22,9.49126111187092e-23,BCL2/CD22/CD28/CD70/CD74/CD80/CD86/CRTAM/FCRL3/HLA-E/IL10/IL12B/IL2RA/LGALS9/LILRB4/PTPRC/TNFRSF13B/TNFRSF13C/TNFRSF1B/TNFRSF4/TNFSF8/VCAM1,22
GO:0032944,GO:0032944,regulation of mononuclear cell proliferation,22/71,233/18800,2.99159964809557e-25,1.76803539202448e-22,9.52588308998853e-23,BCL2/CD22/CD28/CD70/CD74/CD80/CD86/CRTAM/FCRL3/HLA-E/IL10/IL12B/IL2RA/LGALS9/LILRB4/PTPRC/TNFRSF13B/TNFRSF13C/TNFRSF1B/TNFRSF4/TNFSF8/VCAM1,22
GO:1903037,GO:1903037,regulation of leukocyte cell-cell adhesion,24/71,344/18800,2.16125541887036e-24,8.51534635034921e-22,4.58792816988269e-22,ADAM8/B2M/CD27/CD28/CD5/CD70/CD74/CD80/CD83/CD86/CRTAM/HLA-E/IL10/IL12B/IL2RA/KLRK1/LAG3/LGALS9/LILRB4/PTPRC/TIGIT/TNF/TNFRSF13C/VCAM1,24
GO:0002697,GO:0002697,regulation of immune effector process,24/71,353/18800,4.0146794998259996e-24,1.3558146196555201e-21,7.304905556074379e-22,B2M/CD22/CD28/CD74/CD80/CD86/CRTAM/FCER2/FCRL3/HLA-E/IL10/IL12B/KLRK1/LAG3/LGALS9/LILRB4/LTA/PTPRC/SEMA7A/SLAMF6/SLAMF8/TNF/TNFRSF1B/TNFRSF4,24
GO:0002696,GO:0002696,positive regulation of leukocyte activation,25/71,421/18800,1.07974789647169e-23,3.19065503407385e-21,1.71907230885624e-21,ADAM8/B2M/BCL2/CCL3/CD27/CD28/CD5/CD70/CD74/CD80/CD83/CD86/FCRL3/HLA-E/IL10/IL12B/IL2RA/KLRK1/LGALS9/LILRB4/PTPRC/TNF/TNFRSF13C/TNFRSF4/VCAM1,25
GO:0030098,GO:0030098,lymphocyte differentiation,24/71,382/18800,2.6467473856121202e-23,6.25691081958704e-21,3.3711203543059602e-21,ADAM8/B2M/BCL2/CD27/CD28/CD74/CD79B/CD80/CD83/CD86/CRTAM/FCRL3/IL10/IL12B/IL2RA/LAG3/LGALS9/LILRB4/LY9/PTPRC/SLAMF6/SLAMF8/TNFSF8/VCAM1,24
GO:0046651,GO:0046651,lymphocyte proliferation,22/71,296/18800,6.1709895188757e-23,1.21568493521851e-20,6.54990992792947e-21,BCL2/CD22/CD28/CD70/CD74/CD80/CD86/CRTAM/FCRL3/HLA-E/IL10/IL12B/IL2RA/LGALS9/LILRB4/PTPRC/TNFRSF13B/TNFRSF13C/TNFRSF1B/TNFRSF4/TNFSF8/VCAM1,22
GO:0032943,GO:0032943,mononuclear cell proliferation,22/71,300/18800,8.29767318816493e-23,1.4011213869158502e-20,7.54901094562374e-21,BCL2/CD22/CD28/CD70/CD74/CD80/CD86/CRTAM/FCRL3/HLA-E/IL10/IL12B/IL2RA/LGALS9/LILRB4/PTPRC/TNFRSF13B/TNFRSF13C/TNFRSF1B/TNFRSF4/TNFSF8/VCAM1,22
GO:0050870,GO:0050870,positive regulation of T cell activation,19/71,223/18800,5.93798167263252e-21,7.388099302159621e-19,3.98058605201404e-19,ADAM8/B2M/CD27/CD28/CD5/CD70/CD74/CD80/CD83/CD86/HLA-E/IL12B/IL2RA/KLRK1/LGALS9/LILRB4/PTPRC/TNFRSF13C/VCAM1,19
GO:0045619,GO:0045619,regulation of lymphocyte differentiation,17/71,181/18800,1.6115378484193202e-19,1.67299245016365e-17,9.01380739468348e-18,ADAM8/CD27/CD28/CD74/CD80/CD83/CD86/CRTAM/FCRL3/IL10/IL12B/IL2RA/LAG3/LGALS9/LILRB4/PTPRC/SLAMF8,17
GO:0001819,GO:0001819,positive regulation of cytokine production,22/71,475/18800,1.75627131903926e-18,1.53771311044771e-16,8.28494462392791e-17,ADAM8/B2M/CCL3/CD28/CD74/CD80/CD83/CD86/CRTAM/HLA-E/IL10/IL12B/KLRK1/LGALS9/LTA/LY9/PTPRC/SEMA7A/SLAMF6/TIGIT/TNF/TNFRSF8,22
GO:0002449,GO:0002449,lymphocyte mediated immunity,19/71,365/18800,6.46622610639869e-17,4.49592897515486e-15,2.4223323804156102e-15,B2M/CD27/CD28/CD70/CD74/CRTAM/FCER2/HLA-E/IL10/IL12B/KLRK1/LAG3/LGALS9/LILRB4/LTA/PTPRC/SLAMF6/TNF/TNFRSF1B,19
GO:0002460,GO:0002460,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,19/71,370/18800,8.31681457332287e-17,5.617414186095791e-15,3.0265701154047103e-15,B2M/CD27/CD28/CD70/CD74/CD80/CXCL13/FCER2/HLA-E/IL10/IL12B/IL18BP/LILRB4/LTA/LY9/PTPRC/SLAMF6/TNF/TNFRSF1B,19
GO:0046631,GO:0046631,alpha-beta T cell activation,14/71,158/18800,7.784000196552269e-16,4.7183016576024504e-14,2.54214311412368e-14,BCL2/CD28/CD80/CD83/CD86/CRTAM/HLA-E/IL12B/LGALS9/LILRB4/LY9/PTPRC/SLAMF6/TNFSF8,14
GO:0002700,GO:0002700,regulation of production of molecular mediator of immune response,14/71,167/18800,1.7028091627070601e-15,1.0063602151598699e-13,5.42210286019881e-14,B2M/CD22/CD28/CD74/CD86/FCRL3/HLA-E/IL10/LILRB4/PTPRC/SEMA7A/TNF/TNFRSF1B/TNFRSF4,14
GO:0042113,GO:0042113,B cell activation,17/71,336/18800,5.592012586367311e-15,3.22427262296886e-13,1.73718491129767e-13,BCL2/CD22/CD27/CD28/CD70/CD74/CD79B/CD86/FCRL1/FCRL3/IL10/PTPRC/SLAMF8/TNFRSF13B/TNFRSF13C/TNFRSF4/VCAM1,17
GO:0002237,GO:0002237,response to molecule of bacterial origin,16/71,354/18800,2.23041630875454e-13,1.07606207222362e-11,5.79764497012459e-12,B2M/CCL3/CD80/CD86/CXCL13/CXCL9/IL10/IL12B/IL18BP/KLRK1/LGALS9/LTA/NOS3/TNF/TNFRSF1B/VCAM1,16
GO:0002819,GO:0002819,regulation of adaptive immune response,13/71,188/18800,2.30594311405207e-13,1.0902499043238198e-11,5.87408666948e-12,B2M/CD28/CD48/CD80/FCER2/HLA-E/IL10/IL12B/LILRB4/LTA/PTPRC/TNF/TNFRSF1B,13
GO:0050866,GO:0050866,negative regulation of cell activation,13/71,216/18800,1.36751133714694e-12,6.33881725689289e-11,3.4152501918427296e-11,CD74/CD80/CD86/CRTAM/IL10/IL2RA/LAG3/LGALS9/LILRB4/NOS3/PTPRC/TIGIT/TNFRSF13B,13
GO:0031343,GO:0031343,positive regulation of cell killing,9/71,65/18800,2.49754594937386e-12,1.07349065896724e-10,5.783790619602609e-11,B2M/CRTAM/FCER2/HLA-E/IL12B/KLRK1/LAG3/PTPRC/SLAMF6,9
GO:0002440,GO:0002440,production of molecular mediator of immune response,14/71,312/18800,9.24681900990213e-12,3.52572260313042e-10,1.89960118879144e-10,B2M/CD22/CD28/CD74/CD86/FCRL3/HLA-E/IL10/LILRB4/PTPRC/SEMA7A/TNF/TNFRSF1B/TNFRSF4,14
GO:0001910,GO:0001910,regulation of leukocyte mediated cytotoxicity,9/71,85/18800,3.03087710486917e-11,1.08560507210768e-09,5.84906107957208e-10,B2M/CRTAM/HLA-E/IL12B/KLRK1/LAG3/LGALS9/PTPRC/SLAMF6,9
GO:0050868,GO:0050868,negative regulation of T cell activation,10/71,125/18800,3.8430628202335296e-11,1.3559702249301602e-09,7.30574393163012e-10,CD74/CD80/CD86/CRTAM/IL10/IL2RA/LAG3/LGALS9/LILRB4/TIGIT,10
GO:0050900,GO:0050900,leukocyte migration,14/71,384/18800,1.45576459970703e-10,4.98757610682235e-09,2.6872237462174e-09,ADAM8/CCL3/CD74/CRTAM/CXCL13/CXCL9/GCNT1/IL10/KLRK1/LGALS9/SELL/SLAMF8/TNF/VCAM1,14
GO:0050727,GO:0050727,regulation of inflammatory response,14/71,394/18800,2.03981050088613e-10,6.7917070761898904e-09,3.6592597569640104e-09,ADAM8/CCL3/CD28/HLA-E/IL10/IL12B/IL2RA/LTA/PTPRC/SEMA7A/SIGLEC10/SLAMF8/TNF/TNFRSF1B,14
GO:0019221,GO:0019221,cytokine-mediated signaling pathway,15/71,486/18800,3.00889602224708e-10,9.87920860637792e-09,5.32275465923826e-09,CCL3/CD70/CD74/CXCL13/CXCL9/IFNLR1/IL12B/IL2RA/LILRB4/PTPRC/TNF/TNFRSF13C/TNFRSF17/TNFRSF1B/TNFRSF4,15
GO:0042269,GO:0042269,regulation of natural killer cell mediated cytotoxicity,7/71,46/18800,3.85154615291875e-10,1.21400734739999e-08,6.54087136144799e-09,CRTAM/HLA-E/IL12B/KLRK1/LAG3/LGALS9/SLAMF6,7
GO:0032609,GO:0032609,interferon-gamma production,9/71,117/18800,5.52687625714865e-10,1.65386524960752e-08,8.910753192738e-09,CRTAM/IL10/IL12B/KLRK1/LGALS9/LILRB4/LTA/SLAMF6/TNF,9
GO:0019724,GO:0019724,B cell mediated immunity,11/71,219/18800,5.78514348480705e-10,1.70950989976048e-08,9.210557390284911e-09,B2M/CD27/CD28/CD70/CD74/FCER2/HLA-E/IL10/LTA/PTPRC/TNF,11
GO:0032102,GO:0032102,negative regulation of response to external stimulus,14/71,429/18800,6.18981981093684e-10,1.78447976012862e-08,9.61448263316249e-09,CXCL13/HLA-E/IL10/IL12B/IL2RA/KLRK1/LGALS9/NOS3/PTPRC/SEMA7A/SIGLEC10/SLAMF8/TNF/TNFRSF1B,14
GO:0032103,GO:0032103,positive regulation of response to external stimulus,14/71,442/18800,9.11373969835502e-10,2.5052186798734e-08,1.34977050612112e-08,ADAM8/CCL3/CD28/CD74/CRTAM/CXCL13/HLA-E/IL12B/KLRK1/LAG3/LGALS9/LTA/SLAMF6/TNF,14
GO:0001909,GO:0001909,leukocyte mediated cytotoxicity,9/71,131/18800,1.5174076268270502e-09,3.98572403313239e-08,2.14744237246869e-08,B2M/CRTAM/HLA-E/IL12B/KLRK1/LAG3/LGALS9/PTPRC/SLAMF6,9
GO:0001906,GO:0001906,cell killing,10/71,185/18800,1.8322630287526502e-09,4.70811934779486e-08,2.53665705353628e-08,B2M/CRTAM/FCER2/HLA-E/IL12B/KLRK1/LAG3/LGALS9/PTPRC/SLAMF6,10
GO:0071216,GO:0071216,cellular response to biotic stimulus,11/71,256/18800,2.9985812823995903e-09,7.384006407909e-08,3.97838086809595e-08,CCL3/CD80/CD86/CXCL13/CXCL9/IL10/IL12B/KLRK1/NOS3/TNF/TNFRSF1B,11
GO:0002712,GO:0002712,regulation of B cell mediated immunity,7/71,62/18800,3.37388373324156e-09,8.05642539937682e-08,4.34066913048622e-08,CD28/FCER2/HLA-E/IL10/LTA/PTPRC/TNF,7
GO:0002889,GO:0002889,regulation of immunoglobulin mediated immune response,7/71,62/18800,3.37388373324156e-09,8.05642539937682e-08,4.34066913048622e-08,CD28/FCER2/HLA-E/IL10/LTA/PTPRC/TNF,7
GO:0002367,GO:0002367,cytokine production involved in immune response,8/71,100/18800,3.89252818294216e-09,8.93391905288861e-08,4.8134482384875e-08,B2M/CD74/HLA-E/IL10/LILRB4/SEMA7A/TNF/TNFRSF1B,8
GO:0002544,GO:0002544,chronic inflammatory response,5/71,17/18800,3.97659713945056e-09,9.03911119005876e-08,4.87012402705989e-08,CXCL13/IL10/LTA/TNF/VCAM1,5
GO:0002285,GO:0002285,lymphocyte activation involved in immune response,10/71,201/18800,4.0860451583509504e-09,9.1994388136587e-08,4.95650590637057e-08,CD28/CD74/CD80/CD86/IL10/IL12B/LGALS9/LY9/PTPRC/SLAMF6,10
GO:0042267,GO:0042267,natural killer cell mediated cytotoxicity,7/71,72/18800,9.80890128509047e-09,1.981901080167e-07,1.06781561448128e-07,CRTAM/HLA-E/IL12B/KLRK1/LAG3/LGALS9/SLAMF6,7
GO:0002437,GO:0002437,inflammatory response to antigenic stimulus,7/71,75/18800,1.30984738544448e-08,2.4971606606377e-07,1.34542897825791e-07,CD28/HLA-E/IL10/IL12B/IL2RA/LTA/TNF,7
GO:0070227,GO:0070227,lymphocyte apoptotic process,7/71,75/18800,1.30984738544448e-08,2.4971606606377e-07,1.34542897825791e-07,ADAM8/CD27/CD74/IL10/IL2RA/LGALS9/PDCD1,7
GO:0050777,GO:0050777,negative regulation of immune response,9/71,179/18800,2.35746475927888e-08,4.32019123328315e-07,2.32764778353932e-07,FCRLB/HLA-E/IL10/IL12B/LGALS9/LILRB4/PDCD1/PTPRC/SLAMF8,9
GO:0006959,GO:0006959,humoral immune response,11/71,317/18800,2.74216327918916e-08,4.94845342901006e-07,2.66614509266283e-07,BCL2/CD28/CD83/CXCL13/CXCL9/FCER2/HLA-E/LTA/PDCD1/PTPRC/TNF,11
GO:0070228,GO:0070228,regulation of lymphocyte apoptotic process,6/71,57/18800,7.29067196253884e-08,1.24892380575665e-06,6.728995480299e-07,ADAM8/CD27/CD74/IL10/LGALS9/PDCD1,6
GO:0002507,GO:0002507,tolerance induction,5/71,31/18800,1.04803843754603e-07,1.76968776168488e-06,9.53478578519325e-07,HLA-E/IL2RA/LGALS9/LILRB4/PDCD1,5
GO:0002260,GO:0002260,lymphocyte homeostasis,6/71,65/18800,1.62057861824413e-07,2.60615500240077e-06,1.40415333195518e-06,BCL2/CD74/IL2RA/LGALS9/TNFRSF13B/TNFRSF17,6
GO:0030595,GO:0030595,leukocyte chemotaxis,9/71,236/18800,2.516620852382e-07,3.7893577675357e-06,2.04164346723582e-06,ADAM8/CCL3/CD74/CXCL13/CXCL9/IL10/KLRK1/LGALS9/SLAMF8,9
GO:0071675,GO:0071675,regulation of mononuclear cell migration,7/71,116/18800,2.7227570142569e-07,4.02287348856457e-06,2.16745788634924e-06,ADAM8/CCL3/CXCL13/KLRK1/LGALS9/SLAMF8/TNF,7
GO:0034612,GO:0034612,response to tumor necrosis factor,9/71,249/18800,3.95450274252935e-07,5.6657239292966e-06,3.05259860826827e-06,CCL3/CD70/IL18BP/TNF/TNFRSF13C/TNFRSF17/TNFRSF1B/TNFRSF4/VCAM1,9
GO:0002920,GO:0002920,regulation of humoral immune response,5/71,45/18800,7.23345290415741e-07,9.82751877323455e-06,5.2949050296615e-06,CXCL13/FCER2/LTA/PTPRC/TNF,5
GO:0002831,GO:0002831,regulation of response to biotic stimulus,10/71,351/18800,7.60919464866041e-07,1.02205319030871e-05,5.50665402205688e-06,ADAM8/CRTAM/HLA-E/IFNLR1/IL12B/KLRK1/LAG3/LGALS9/SLAMF6/SLAMF8,10
GO:0051043,GO:0051043,regulation of membrane protein ectodomain proteolysis,4/71,24/18800,1.87415083270079e-06,2.33183819394982e-05,1.25635595987144e-05,ADAM8/IL10/TNF/TNFRSF1B,4
GO:1901224,GO:1901224,positive regulation of NIK/NF-kappaB signaling,5/71,67/18800,5.36151680536199e-06,6.30578394421679e-05,3.39745238779157e-05,CD27/CD86/IL12B/LGALS9/TNF,5
GO:0042742,GO:0042742,defense response to bacterium,9/71,364/18800,8.95817235593946e-06,9.94230960067647e-05,5.35675243424104e-05,CXCL13/HLA-E/IL10/IL12B/KLRK1/LTA/SLAMF8/TNF/TNFSF8,9
GO:0002478,GO:0002478,antigen processing and presentation of exogenous peptide antigen,4/71,38/18800,1.25098225451169e-05,0.0001362821221044,7.34265596875648e-05,B2M/CD74/HLA-E/IFI30,4
GO:0002429,GO:0002429,immune response-activating cell surface receptor signaling pathway,8/71,300/18800,1.70398277935885e-05,0.0001766761092282,9.51901737314961e-05,BCL2/CD22/CD28/CD79B/FCRL3/KLRK1/LILRB4/PTPRC,8
GO:0097191,GO:0097191,extrinsic apoptotic signaling pathway,7/71,221/18800,1.98144466381512e-05,0.0002036580515329,0.0001097275992318,BCL2/CD27/CD70/NOS3/PTPRC/TNF/TNFRSF1B,7
GO:0050920,GO:0050920,regulation of chemotaxis,7/71,225/18800,2.22372920758004e-05,0.0002275712487757,0.0001226116355056,CCL3/CD74/CXCL13/KLRK1/LGALS9/SEMA7A/SLAMF8,7
GO:0006509,GO:0006509,membrane protein ectodomain proteolysis,4/71,44/18800,2.26166869607144e-05,0.0002304562412721,0.0001241660218805,ADAM8/IL10/TNF/TNFRSF1B,4
GO:0019058,GO:0019058,viral life cycle,8/71,317/18800,2.52987989202665e-05,0.000254514138485,0.0001371280201117,BCL2/CD28/CD74/CD80/CD86/LGALS9/TNF/TNFRSF4,8
GO:0002274,GO:0002274,myeloid leukocyte activation,7/71,232/18800,2.70646429247641e-05,0.0002699612484141,0.0001454506681721,CCL3/CD74/IL10/LGALS9/LILRB4/PTPRC/TNF,7
GO:0035094,GO:0035094,response to nicotine,4/71,49/18800,3.48005883950588e-05,0.0003371663564177,0.00018165967195,B2M/BCL2/TNF/VCAM1,4
GO:0034113,GO:0034113,heterotypic cell-cell adhesion,4/71,61/18800,8.28380788764274e-05,0.000736200069413,0.0003966524552452,IL10/PTPRC/TNF/VCAM1,4
GO:0150076,GO:0150076,neuroinflammatory response,4/71,73/18800,0.0001669822805109,0.0013291114852787,0.0007161033472202,CCL3/PTPRC/TNF/TNFRSF1B,4
GO:0031644,GO:0031644,regulation of nervous system process,5/71,138/18800,0.0001749092451187,0.0013875350854388,0.0007475810194055,CCL3/IL10/NOS3/TNF/TNFRSF1B,5
GO:1903900,GO:1903900,regulation of viral life cycle,5/71,139/18800,0.0001809077882881,0.0014255533717103,0.0007680646450127,BCL2/CD28/CD74/LGALS9/TNF,5
GO:0006809,GO:0006809,nitric oxide biosynthetic process,4/71,75/18800,0.0001854129284652,0.0014513780228206,0.0007819785411047,IL10/KLRK1/NOS3/TNF,4
GO:0034341,GO:0034341,response to interferon-gamma,5/71,140/18800,0.000187062221885,0.0014594557509446,0.0007863306877918,CCL3/CD74/IL12B/LGALS9/TNF,5
GO:0046718,GO:0046718,viral entry into host cell,5/71,146/18800,0.0002274160115162,0.0017342304878204,0.0009343747841582,CD74/CD80/CD86/LGALS9/TNFRSF4,5
GO:0046209,GO:0046209,nitric oxide metabolic process,4/71,81/18800,0.0002495111204532,0.0018966054300694,0.0010218597249906,IL10/KLRK1/NOS3/TNF,4
GO:2001057,GO:2001057,reactive nitrogen species metabolic process,4/71,82/18800,0.0002615630756419,0.0019755115361583,0.0010643730335522,IL10/KLRK1/NOS3/TNF,4
GO:0071316,GO:0071316,cellular response to nicotine,2/71,7/18800,0.0002917196447783,0.0021686328309938,0.0011684236020583,B2M/TNF,2
GO:0042092,GO:0042092,type 2 immune response,3/71,37/18800,0.0003657612865034,0.0026852785133361,0.0014467837746623,CD74/CD86/IL10,3
GO:0045191,GO:0045191,regulation of isotype switching,3/71,38/18800,0.0003960399834141,0.0028457097896388,0.0015332215003397,CD28/IL10/PTPRC,3
GO:0051048,GO:0051048,negative regulation of secretion,5/71,167/18800,0.0004225721241727,0.0030226057148106,0.0016285301072761,CD74/IL12B/LGALS9/TNF/TNFRSF1B,5
GO:0050730,GO:0050730,regulation of peptidyl-tyrosine phosphorylation,6/71,261/18800,0.0004551241178784,0.0032212976486964,0.0017355820442259,CD74/CD80/IL12B/LILRB4/PTPRC/TNF,6
GO:0019233,GO:0019233,sensory perception of pain,4/71,99/18800,0.0005364438099776,0.0036864917639158,0.0019862209610553,CCL3/IL10/IL12B/TNF,4
GO:0008630,GO:0008630,intrinsic apoptotic signaling pathway in response to DNA damage,4/71,101/18800,0.000578550178836,0.0039528688519319,0.0021297405427187,BCL2/CD74/TNF/TNFRSF1B,4
GO:0046427,GO:0046427,positive regulation of receptor signaling pathway via JAK-STAT,3/71,45/18800,0.0006536869880765,0.0043407753927329,0.0023387381891561,IL10/IL12B/TNF,3
GO:0009615,GO:0009615,response to virus,7/71,392/18800,0.0006858993907845,0.0045292350832809,0.002440277162156,BCL2/CXCL9/IFNLR1/IL12B/LGALS9/PTPRC/TNF,7
GO:0051341,GO:0051341,regulation of oxidoreductase activity,4/71,106/18800,0.0006940198953936,0.0045447729437969,0.0024486487051359,FCER2/GZMA/SLAMF8/TNF,4
GO:0040013,GO:0040013,negative regulation of locomotion,7/71,396/18800,0.0007281011630879,0.0047286570042303,0.0025477224040959,BCL2/CD74/CXCL13/KLRK1/SEMA7A/SLAMF8/TNF,7
GO:0075294,GO:0075294,positive regulation by symbiont of entry into host,2/71,11/18800,0.0007565894357619,0.0048339930436248,0.0026044757248134,CD74/LGALS9,2
GO:0002526,GO:0002526,acute inflammatory response,4/71,113/18800,0.0008818803757214,0.0055445883196952,0.0029873327397057,ADAM8/HLA-E/TNF/VCAM1,4
GO:0002269,GO:0002269,leukocyte activation involved in inflammatory response,3/71,50/18800,0.0008908011634781,0.0055858194972478,0.0030095474181449,CCL3/PTPRC/TNF,3
GO:0045190,GO:0045190,isotype switching,3/71,52/18800,0.0009990174730432,0.006118334990348,0.0032964579830444,CD28/IL10/PTPRC,3
GO:1900121,GO:1900121,negative regulation of receptor binding,2/71,13/18800,0.0010677498083252,0.0064320675400535,0.0034654919064319,B2M/IL10,2
GO:0043523,GO:0043523,regulation of neuron apoptotic process,5/71,207/18800,0.0011137302456247,0.006674361190226,0.0035960357289934,ADAM8/BCL2/CCL3/IL10/TNF,5
GO:1901214,GO:1901214,regulation of neuron death,6/71,313/18800,0.0011725332913843,0.0069524009791355,0.0037458389815451,ADAM8/BCL2/CCL3/IL10/TNF/TNFRSF1B,6
GO:0002839,GO:0002839,positive regulation of immune response to tumor cell,2/71,15/18800,0.0014303511191009,0.0081675121873299,0.0044005208596799,CRTAM/IL12B,2
GO:1902166,GO:1902166,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,2/71,15/18800,0.0014303511191009,0.0081675121873299,0.0044005208596799,BCL2/CD74,2
GO:0043666,GO:0043666,regulation of phosphoprotein phosphatase activity,3/71,59/18800,0.001442069626516,0.0081948379737597,0.0044152435427238,FCRL3/PTPRC/TNF,3
GO:1902893,GO:1902893,regulation of miRNA transcription,3/71,59/18800,0.001442069626516,0.0081948379737597,0.0044152435427238,IL10/LILRB4/TNF,3
GO:0061614,GO:0061614,miRNA transcription,3/71,60/18800,0.0015138824238173,0.0085617656696274,0.0046129381335155,IL10/LILRB4/TNF,3
GO:0045428,GO:0045428,regulation of nitric oxide biosynthetic process,3/71,61/18800,0.0015879019589005,0.0089376195972401,0.0048154420307509,IL10/KLRK1/TNF,3
GO:0010224,GO:0010224,response to UV-B,2/71,16/18800,0.0016307007390057,0.009156713888384,0.0049334864212951,BCL2/IL12B,2
GO:0014015,GO:0014015,positive regulation of gliogenesis,3/71,64/18800,0.001823446110259,0.0099961522289217,0.0053857619543126,LTA/TNF/TNFRSF1B,3
GO:0080164,GO:0080164,regulation of nitric oxide metabolic process,3/71,64/18800,0.001823446110259,0.0099961522289217,0.0053857619543126,IL10/KLRK1/TNF,3
GO:0032604,GO:0032604,granulocyte macrophage colony-stimulating factor production,2/71,17/18800,0.0018436219846911,0.0099961522289217,0.0053857619543126,CD80/IL12B,2
GO:0060252,GO:0060252,positive regulation of glial cell proliferation,2/71,17/18800,0.0018436219846911,0.0099961522289217,0.0053857619543126,LTA/TNF,2
GO:0070997,GO:0070997,neuron death,6/71,353/18800,0.0021563171710441,0.0114294479649066,0.0061579980575015,ADAM8/BCL2/CCL3/IL10/TNF/TNFRSF1B,6
GO:0051402,GO:0051402,neuron apoptotic process,5/71,241/18800,0.0021735711017693,0.0114951277060016,0.0061933852187469,ADAM8/BCL2/CCL3/IL10/TNF,5
GO:1903978,GO:1903978,regulation of microglial cell activation,2/71,20/18800,0.0025568670079625,0.0130267965664297,0.007018623138917,CCL3/PTPRC,2
GO:0051924,GO:0051924,regulation of calcium ion transport,5/71,251/18800,0.0025917869692443,0.0131763105275132,0.0070991787952137,BCL2/CCL3/CXCL9/FCRL3/NOS3,5
GO:0048662,GO:0048662,negative regulation of smooth muscle cell proliferation,3/71,73/18800,0.0026568941832208,0.013420721899859,0.0072308636115546,IL10/IL12B/NOS3,3
GO:0051346,GO:0051346,negative regulation of hydrolase activity,6/71,371/18800,0.0027618735492513,0.0138469182280862,0.0074604911639434,CD27/GZMA/KLRK1/NOS3/SERPINA9/TNF,6
GO:0060284,GO:0060284,regulation of cell development,7/71,500/18800,0.0027646977172828,0.0138469182280862,0.0074604911639434,B2M/BCL2/LTA/SEMA7A/SLAMF8/TNF/TNFRSF1B,7
GO:0003177,GO:0003177,pulmonary valve development,2/71,21/18800,0.0028191288856812,0.0140303593384219,0.0075593262086964,NOS3/TNFRSF1B,2
GO:0051000,GO:0051000,positive regulation of nitric-oxide synthase activity,2/71,22/18800,0.0030934920423308,0.0151095355125415,0.0081407685324495,FCER2/TNF,2
GO:0048145,GO:0048145,regulation of fibroblast proliferation,3/71,79/18800,0.003324049153272,0.0161391539472387,0.0086955099635581,CD74/IFI30/LTA,3
GO:0045165,GO:0045165,cell fate commitment,5/71,266/18800,0.0033247749459836,0.0161391539472387,0.0086955099635581,BCL2/IL12B/LY9/SLAMF6/SLAMF8,5
GO:1900120,GO:1900120,regulation of receptor binding,2/71,23/18800,0.0033798639531044,0.0162398341161361,0.0087497547780411,B2M/IL10,2
GO:0051962,GO:0051962,positive regulation of nervous system development,5/71,270/18800,0.003543152966626,0.0169409342323063,0.0091274959573829,CLSTN3/LTA/SEMA7A/TNF/TNFRSF1B,5
GO:0048144,GO:0048144,fibroblast proliferation,3/71,81/18800,0.0035671662554,0.0169409342323063,0.0091274959573829,CD74/IFI30/LTA,3
GO:1903034,GO:1903034,regulation of response to wounding,4/71,166/18800,0.0035976046438082,0.0169409342323063,0.0091274959573829,IL10/NOS3/SIGLEC10/TNF,4
GO:0001815,GO:0001815,positive regulation of antibody-dependent cellular cytotoxicity,1/71,1/18800,0.0037765957446808,0.0169409342323063,0.0091274959573829,HLA-E,1
GO:0014740,GO:0014740,negative regulation of muscle hyperplasia,1/71,1/18800,0.0037765957446808,0.0169409342323063,0.0091274959573829,NOS3,1
GO:0032078,GO:0032078,negative regulation of endodeoxyribonuclease activity,1/71,1/18800,0.0037765957446808,0.0169409342323063,0.0091274959573829,GZMA,1
GO:0032848,GO:0032848,negative regulation of cellular pH reduction,1/71,1/18800,0.0037765957446808,0.0169409342323063,0.0091274959573829,BCL2,1
GO:0045994,GO:0045994,positive regulation of translational initiation by iron,1/71,1/18800,0.0037765957446808,0.0169409342323063,0.0091274959573829,TNF,1
GO:0046671,GO:0046671,negative regulation of retinal cell programmed cell death,1/71,1/18800,0.0037765957446808,0.0169409342323063,0.0091274959573829,BCL2,1
GO:0060945,GO:0060945,cardiac neuron differentiation,1/71,1/18800,0.0037765957446808,0.0169409342323063,0.0091274959573829,VCAM1,1
GO:0061048,GO:0061048,negative regulation of branching involved in lung morphogenesis,1/71,1/18800,0.0037765957446808,0.0169409342323063,0.0091274959573829,TNF,1
GO:0071283,GO:0071283,cellular response to iron(III) ion,1/71,1/18800,0.0037765957446808,0.0169409342323063,0.0091274959573829,B2M,1
GO:0140460,GO:0140460,response to Gram-negative bacterium,1/71,1/18800,0.0037765957446808,0.0169409342323063,0.0091274959573829,TNF,1
GO:1901554,GO:1901554,response to paracetamol,1/71,1/18800,0.0037765957446808,0.0169409342323063,0.0091274959573829,TNF,1
GO:1902483,GO:1902483,cytotoxic T cell pyroptotic process,1/71,1/18800,0.0037765957446808,0.0169409342323063,0.0091274959573829,GZMA,1
GO:0010921,GO:0010921,regulation of phosphatase activity,3/71,84/18800,0.0039517837318379,0.0176597669982325,0.0095147911959485,FCRL3/PTPRC/TNF,3
GO:0006929,GO:0006929,substrate-dependent cell migration,2/71,25/18800,0.0039882664809372,0.0177222969190519,0.0095484812859795,ADAM8/PTPRC,2
GO:0060402,GO:0060402,calcium ion transport into cytosol,4/71,171/18800,0.0039986581736071,0.017735136815023,0.0095553992101602,BCL2/CCL3/CXCL9/PTPRC,4
GO:0098742,GO:0098742,cell-cell adhesion via plasma-membrane adhesion molecules,5/71,279/18800,0.004072010241608,0.0180266520808267,0.0097124628274113,CLSTN3/CRTAM/IL10/SELL/VCAM1,5
GO:0048659,GO:0048659,smooth muscle cell proliferation,4/71,173/18800,0.0041672251343936,0.0182770319437969,0.0098473633680623,IL10/IL12B/NOS3/TNF,4
GO:0034599,GO:0034599,cellular response to oxidative stress,5/71,284/18800,0.0043891153268645,0.0190382910691886,0.0102575172293696,BCL2/IL10/IL18BP/NOS3/TNF,5
GO:0001666,GO:0001666,response to hypoxia,5/71,286/18800,0.0045207680968542,0.01957343549627,0.0105458442205391,ADAM8/BCL2/LTA/TNF/VCAM1,5
GO:0002418,GO:0002418,immune response to tumor cell,2/71,27/18800,0.0046436064092337,0.0199742287577146,0.0107617850195185,CRTAM/IL12B,2
GO:0048873,GO:0048873,homeostasis of number of cells within a tissue,2/71,28/18800,0.0049886519524774,0.0211726628647338,0.0114074815505958,BCL2/NOS3,2
GO:0006816,GO:0006816,calcium ion transport,6/71,424/18800,0.0052930811649527,0.0223156921713489,0.0120233268890071,BCL2/CCL3/CXCL9/FCRL3/NOS3/PTPRC,6
GO:0097421,GO:0097421,liver regeneration,2/71,29/18800,0.005345161707487,0.0223645350026536,0.0120496426009488,IL10/TNF,2
GO:1903203,GO:1903203,regulation of oxidative stress-induced neuron death,2/71,29/18800,0.005345161707487,0.0223645350026536,0.0120496426009488,IL10/TNF,2
GO:0060251,GO:0060251,regulation of glial cell proliferation,2/71,30/18800,0.0057130466624468,0.0235700563874772,0.0126991576404165,LTA/TNF,2
GO:0070168,GO:0070168,negative regulation of biomineral tissue development,2/71,30/18800,0.0057130466624468,0.0235700563874772,0.0126991576404165,CCL3/NOS3,2
GO:0002532,GO:0002532,production of molecular mediator involved in inflammatory response,3/71,97/18800,0.0059053190843455,0.0241108364687271,0.0129905210291031,LILRB4/SLAMF8/TNF,3
GO:1990868,GO:1990868,response to chemokine,3/71,97/18800,0.0059053190843455,0.0241108364687271,0.0129905210291031,CCL3/CXCL13/CXCL9,3
GO:0010039,GO:0010039,response to iron ion,2/71,31/18800,0.0060922182978172,0.0246188103522051,0.0132642089795031,B2M/BCL2,2
GO:0061099,GO:0061099,negative regulation of protein tyrosine kinase activity,2/71,31/18800,0.0060922182978172,0.0246188103522051,0.0132642089795031,LILRB4/PTPRC,2
GO:0110150,GO:0110150,negative regulation of biomineralization,2/71,31/18800,0.0060922182978172,0.0246188103522051,0.0132642089795031,CCL3/NOS3,2
GO:1901099,GO:1901099,negative regulation of signal transduction in absence of ligand,2/71,33/18800,0.0068840699788373,0.0271685165775818,0.014637948641408,BCL2/TNF,2
GO:1901797,GO:1901797,negative regulation of signal transduction by p53 class mediator,2/71,34/18800,0.0072965754255663,0.0277177306915999,0.0149338561478475,BCL2/CD74,2
GO:0000302,GO:0000302,response to reactive oxygen species,4/71,203/18800,0.0072990777024048,0.0277177306915999,0.0149338561478475,BCL2/IL10/IL18BP/NOS3,4
GO:0002037,GO:0002037,negative regulation of L-glutamate import across plasma membrane,1/71,2/18800,0.0075391289486881,0.0277177306915999,0.0149338561478475,TNF,1
GO:0014806,GO:0014806,smooth muscle hyperplasia,1/71,2/18800,0.0075391289486881,0.0277177306915999,0.0149338561478475,NOS3,1
GO:0044855,GO:0044855,plasma membrane raft distribution,1/71,2/18800,0.0075391289486881,0.0277177306915999,0.0149338561478475,PTPRC,1
GO:0044856,GO:0044856,plasma membrane raft localization,1/71,2/18800,0.0075391289486881,0.0277177306915999,0.0149338561478475,PTPRC,1
GO:0060557,GO:0060557,positive regulation of vitamin D biosynthetic process,1/71,2/18800,0.0075391289486881,0.0277177306915999,0.0149338561478475,TNF,1
GO:0072564,GO:0072564,blood microparticle formation,1/71,2/18800,0.0075391289486881,0.0277177306915999,0.0149338561478475,TNF,1
GO:0120190,GO:0120190,negative regulation of bile acid secretion,1/71,2/18800,0.0075391289486881,0.0277177306915999,0.0149338561478475,TNF,1
GO:0140039,GO:0140039,cell-cell adhesion in response to extracellular stimulus,1/71,2/18800,0.0075391289486881,0.0277177306915999,0.0149338561478475,VCAM1,1
GO:1904432,GO:1904432,regulation of ferrous iron binding,1/71,2/18800,0.0075391289486881,0.0277177306915999,0.0149338561478475,B2M,1
GO:1904434,GO:1904434,positive regulation of ferrous iron binding,1/71,2/18800,0.0075391289486881,0.0277177306915999,0.0149338561478475,B2M,1
GO:1904437,GO:1904437,positive regulation of transferrin receptor binding,1/71,2/18800,0.0075391289486881,0.0277177306915999,0.0149338561478475,B2M,1
GO:1990267,GO:1990267,response to transition metal nanoparticle,1/71,2/18800,0.0075391289486881,0.0277177306915999,0.0149338561478475,TNF,1
GO:1990268,GO:1990268,response to gold nanoparticle,1/71,2/18800,0.0075391289486881,0.0277177306915999,0.0149338561478475,TNF,1
GO:2000332,GO:2000332,regulation of blood microparticle formation,1/71,2/18800,0.0075391289486881,0.0277177306915999,0.0149338561478475,TNF,1
GO:2000334,GO:2000334,positive regulation of blood microparticle formation,1/71,2/18800,0.0075391289486881,0.0277177306915999,0.0149338561478475,TNF,1
GO:2000471,GO:2000471,regulation of hematopoietic stem cell migration,1/71,2/18800,0.0075391289486881,0.0277177306915999,0.0149338561478475,PTPRC,1
GO:2000473,GO:2000473,positive regulation of hematopoietic stem cell migration,1/71,2/18800,0.0075391289486881,0.0277177306915999,0.0149338561478475,PTPRC,1
GO:0007204,GO:0007204,positive regulation of cytosolic calcium ion concentration,5/71,325/18800,0.0076865129382378,0.0281719636992159,0.0151785894006818,BCL2/CCL3/CXCL13/CXCL9/PTPRC,5
GO:0051235,GO:0051235,maintenance of location,5/71,331/18800,0.0082829079684676,0.0301707156201196,0.016255483970231,CCL3/CXCL9/IL10/PTPRC/TNF,5
GO:0030279,GO:0030279,negative regulation of ossification,2/71,37/18800,0.0085993727377466,0.0311793207853269,0.0167989037983104,BCL2/CCL3,2
GO:0033674,GO:0033674,positive regulation of kinase activity,6/71,476/18800,0.0091325955078213,0.032810723070653,0.0176778764429113,ADAM8/CD74/CD86/IL12B/PTPRC/TNF,6
GO:0043406,GO:0043406,positive regulation of MAP kinase activity,3/71,116/18800,0.0096484409108504,0.0346114025997732,0.0186480528745772,ADAM8/PTPRC/TNF,3
GO:0045471,GO:0045471,response to ethanol,3/71,119/18800,0.0103402477916986,0.0369808559448948,0.019924675257513,CD27/TNF/VCAM1,3
GO:0051209,GO:0051209,release of sequestered calcium ion into cytosol,3/71,121/18800,0.0108170885140465,0.0376361177824935,0.0202777195283717,CCL3/CXCL9/PTPRC,3
GO:0002347,GO:0002347,response to tumor cell,2/71,42/18800,0.0109831963279919,0.0376361177824935,0.0202777195283717,CRTAM/IL12B,2
GO:0050691,GO:0050691,regulation of defense response to virus by host,2/71,42/18800,0.0109831963279919,0.0376361177824935,0.0202777195283717,IFNLR1/IL12B,2
GO:0019730,GO:0019730,antimicrobial humoral response,3/71,122/18800,0.0110602227636294,0.0376361177824935,0.0202777195283717,CXCL13/CXCL9/HLA-E,3
GO:0051283,GO:0051283,negative regulation of sequestering of calcium ion,3/71,122/18800,0.0110602227636294,0.0376361177824935,0.0202777195283717,CCL3/CXCL9/PTPRC,3
GO:0002355,GO:0002355,detection of tumor cell,1/71,3/18800,0.0112876512300287,0.0376361177824935,0.0202777195283717,CRTAM,1
GO:0006808,GO:0006808,regulation of nitrogen utilization,1/71,3/18800,0.0112876512300287,0.0376361177824935,0.0202777195283717,BCL2,1
GO:0010693,GO:0010693,negative regulation of alkaline phosphatase activity,1/71,3/18800,0.0112876512300287,0.0376361177824935,0.0202777195283717,TNF,1
GO:0014042,GO:0014042,positive regulation of neuron maturation,1/71,3/18800,0.0112876512300287,0.0376361177824935,0.0202777195283717,BCL2,1
GO:0021747,GO:0021747,cochlear nucleus development,1/71,3/18800,0.0112876512300287,0.0376361177824935,0.0202777195283717,BCL2,1
GO:0046103,GO:0046103,inosine biosynthetic process,1/71,3/18800,0.0112876512300287,0.0376361177824935,0.0202777195283717,ADA2,1
GO:1901647,GO:1901647,positive regulation of synoviocyte proliferation,1/71,3/18800,0.0112876512300287,0.0376361177824935,0.0202777195283717,TNF,1
GO:1905451,GO:1905451,positive regulation of Fc-gamma receptor signaling pathway involved in phagocytosis,1/71,3/18800,0.0112876512300287,0.0376361177824935,0.0202777195283717,PTPRC,1
GO:2000978,GO:2000978,negative regulation of forebrain neuron differentiation,1/71,3/18800,0.0112876512300287,0.0376361177824935,0.0202777195283717,B2M,1
GO:2001272,GO:2001272,positive regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis,1/71,3/18800,0.0112876512300287,0.0376361177824935,0.0202777195283717,TNF,1
GO:0045840,GO:0045840,positive regulation of mitotic nuclear division,2/71,44/18800,0.0120091425293005,0.0393753300128521,0.0212147783932456,CD28/TNF,2
GO:0051452,GO:0051452,intracellular pH reduction,2/71,44/18800,0.0120091425293005,0.0393753300128521,0.0212147783932456,BCL2/SLAMF8,2
GO:1904646,GO:1904646,cellular response to amyloid-beta,2/71,45/18800,0.0125373032521481,0.0408802550180387,0.0220256071652983,TNF/VCAM1,2
GO:1904707,GO:1904707,positive regulation of vascular associated smooth muscle cell proliferation,2/71,46/18800,0.0130754803528254,0.0423430624028482,0.022813743658138,IL10/TNF,2
GO:0000018,GO:0000018,regulation of DNA recombination,3/71,131/18800,0.0133910830567331,0.0432466124946955,0.0233005615453654,CD28/IL10/PTPRC,3
GO:0045776,GO:0045776,negative regulation of blood pressure,2/71,47/18800,0.0136235928737727,0.0438179232021751,0.0236083743319226,NOS3/TNF,2
GO:0042311,GO:0042311,vasodilation,2/71,48/18800,0.0141815603109189,0.0454887497625675,0.0245085881257043,NOS3/TNF,2
GO:0009636,GO:0009636,response to toxic substance,4/71,247/18800,0.0142182944719232,0.0455064265395085,0.0245181120815768,BCL2/CCL3/NOS3/TNF,4
GO:0002941,GO:0002941,synoviocyte proliferation,1/71,4/18800,0.0150222140199774,0.045881800960241,0.0247203576284138,TNF,1
GO:0003332,GO:0003332,negative regulation of extracellular matrix constituent secretion,1/71,4/18800,0.0150222140199774,0.045881800960241,0.0247203576284138,TNFRSF1B,1
GO:0006154,GO:0006154,adenosine catabolic process,1/71,4/18800,0.0150222140199774,0.045881800960241,0.0247203576284138,ADA2,1
GO:0019740,GO:0019740,nitrogen utilization,1/71,4/18800,0.0150222140199774,0.045881800960241,0.0247203576284138,BCL2,1
GO:0046136,GO:0046136,positive regulation of vitamin metabolic process,1/71,4/18800,0.0150222140199774,0.045881800960241,0.0247203576284138,TNF,1
GO:0150098,GO:0150098,glial cell-neuron signaling,1/71,4/18800,0.0150222140199774,0.045881800960241,0.0247203576284138,TNFRSF1B,1
GO:1901671,GO:1901671,positive regulation of superoxide dismutase activity,1/71,4/18800,0.0150222140199774,0.045881800960241,0.0247203576284138,TNF,1
GO:1905242,GO:1905242,"response to 3,3',5-triiodo-L-thyronine",1/71,4/18800,0.0150222140199774,0.045881800960241,0.0247203576284138,TNF,1
GO:2000545,GO:2000545,negative regulation of endothelial cell chemotaxis to fibroblast growth factor,1/71,4/18800,0.0150222140199774,0.045881800960241,0.0247203576284138,CXCL13,1
GO:0043457,GO:0043457,regulation of cellular respiration,2/71,50/18800,0.0153267401718228,0.0465712259205515,0.0250918084263368,IFNLR1/TNF,2
GO:0051384,GO:0051384,response to glucocorticoid,3/71,139/18800,0.0156808941745049,0.0475251715750378,0.0256057786115397,BCL2/IL10/TNF,3
GO:0010212,GO:0010212,response to ionizing radiation,3/71,142/18800,0.0165929779723709,0.0499055978711004,0.0268883130394654,BCL2/PTPRC/VCAM1,3
